Fig. 1From: A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trialARISTOCRAT trial schemaOverview of ARISTOCRAT trialGBM: Glioblastoma; MGMT: O6-Methylguanine-DNA-methyltransferaseBack to article page